öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÑôÖ¾¾ü
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º124

ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧ
ËùÊôԺϵ£ºÖ×ÁöҽѧԺ
Ö°³Æ£ºÖ÷ÈÎҽʦ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÖ×Áöѧ¡¢¸¾²ú¿Æѧ(öλÔÓéÀֵǼÈë¿ÚÏÂÔØÐÍ)
Ñо¿ÁìÓò£º Âѳ²°©»ù´¡ÓëÁÙ´²Ñо¿
Ñо¿ÁìÓò£º Âѳ²°©»ù´¡ÓëÁÙ´²Ñо¿ [ÊÕÆð]




¸öÈ˼òÊö :
ÑôÖ¾¾ü£¬ÄУ¬1975Äê2Ô³öÉúÓÚ¹ãÎ÷¹ðÁÖ£¬Å©¹¤Ãñ×åµ³£¬²©Ê¿£¬¸¾²ú¿ÆÖ÷ÈÎҽʦ£¬²©Ê¿¡¢Ë¶Ê¿Ñо¿Éúµ¼Ê¦¡£¹ãÎ÷µÚÊ®ÆßÅú¡°ÐÂÊÀ¼ÍÊ®°ÙǧÈ˲Ź¤³Ì¡±µÚ¶þ²ã´ÎÈËÑ¡¡£ÈëÑ¡¹ãÎ÷ҽѧ¸ß²ã´Î¹Ç¸ÉÈ˲š°139¡±¼Æ»®ÅàÑø¼Æ»®ÖÐÇàÄêѧ¿Æ¹Ç¸É¡£ÖлªÒ½Ñ§»á¸¾¿ÆÖ×Áöѧ·Ö»áµÚ¶þ½ìίԱ»áÇàÄêίԱ»áίԱ£¬Öйú¿¹°©Ð­»á¸¾¿ÆÖ×ÁööλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áµÚÒ»½ìÇàÄêίԱ»áίԱ£¬¹ãÎ÷¿¹°©Ð­»á³£ÎñÀíʼ渱ÃØÊ鳤£¬¹ãÎ÷¿¹°©Ð­»á¸¾¿ÆÖ×ÁööλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±Ö÷ÈÎίԱ¡£ÏÖÈιãÎ÷Ò½¿Æ´óѧ¸½ÊôÖ×ÁöÒ½Ôº¿ÆÑпƿƳ¤¡£¶Ô¸¾¿ÆÖ×Áö¶ñÐÔÖ×ÁöÊÖÊõ¡¢»¯ÁÆ¡¢·ÅÁÆÓнÏÉîÔìÒ裬É󤸹ǻ¾µÊÖÊõÖÎÁƸ¾¿ÆÁ¼¶ñÐÔÖ×Áö¼°ÍíÆÚ¡¢¸´·¢¶ñÐÔÖ×ÁöµÄ¶àѧ¿ÆÁªºÏÕïÁÆ¡£Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿1Ï¹ãÎ÷׳×å×ÔÖÎÇø¿Æ¼¼Ìü¿ÎÌâ3Ïî¡¢ÎÀÉúÌü¿ÎÌâ3Ï²ÎÓë¡°973¡±ÏîÄ¿Ò»Ï²ÎÓë¶àÏî¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¡¢¿Æ¼¼Ìü¡¢ÎÀÉúÌü¿ÎÌâ¡£»ñ¹ãÎ÷µÚÊ®¶þ½ìÇàÄê¿Æ¼¼½ø²½½±¡¢¹ãÎ÷¿Æ¼¼½ø²½½±¶þµÈ½±Ò»ÏÅÅÃûµÚÒ»£©¡¢¹ãÎ÷¿Æ¼¼½ø²½½±ÈýµÈ½±1ÏÅÅÃûµÚÒ»£©¡¢ÖлªÒ½Ñ§¿Æ¼¼½±Ò»µÈ½±£¨ÅÅÃûµÚÎ壩¡¢¹ãÎ÷Ò½Ò©ÎÀÉúÊÊÒ˼¼ÊõÍƹ㽱һµÈ½±1ÏÅÅÃûµÚÒ»£©¡¢¹ãÎ÷Ò½Ò©ÎÀÉúÊÊÒ˼¼ÊõÍƹ㽱¶þµÈ½±1ÏÅÅÃûµÚÒ»£©¡¢»ñ¹ãÎ÷¿Æѧ¼¼ÊõЭ»á¡°¹ãÎ÷×ÔÈ»¿ÆѧÓÅÐãÂÛÎĽ±¡±Ò»µÈ1ÏÅÅÃûµÚÒ»£©¡¢»ñ¹ãÎ÷½ÌÓýÌü¡°µÚ¶þ½ì¹ãÎ÷¸ßУ½ÌÓý¼¼Êõ½ÌѧӦÓôóÈü¡±¶þµÈ½±£¨ÅÅÃûµÚ¶þ£©¡¢¹ãÎ÷½ÌÓýÌü¡°¹ãÎ÷¸ßµÈ½ÌÓý×ÔÖÎÇø¼¶½Ìѧ³É¹û½±¡±ÈýµÈ½±£¨ÅÅÃûµÚËÄ£©¡¢»ñ¹ãÎ÷½ÌÓýÌü¡°¹ãÎ÷¸ßµÈ½ÌÓý½ÌѧÈí¼þ´óÈü¡±?¶þµÈ½±£¨ÅÅÃûµÚÎ壩£¬ÒÔµÚÒ»×÷Õß»òͨѶ×÷Õß·¢±íSCIÂÛÎÄ5ƪ¡¢Öлª¸¾²ú¿ÆÔÓÖ¾ÂÛÎÄ9ƪ¡¢ÆäËü±±Í¼ÖÐÎĺËÐÄÆÚ¿¯ÂÛÎÄ8ƪ£¬¹²¼ÆѧÊõÂÛÎÄ43ƪ£¬²ÎÓë±àÖø2±¾¡£½ÌÓý±³¾°£º2003.9£­2008.7£¬¹ãÎ÷Ò½¿Æ´óѧÑо¿ÉúѧԺ£¬Ë¶²©Á¬¶Á£»?1992.9£­1997.7¹ãÎ÷Ò½¿Æ´óѧÁÙ´²Ò½ÁÆϵ£¬±¾¿Æ£»

¿ÆÑй¤×÷ :
¹¤×÷¾­Àú£º
2008.7ÖÁ½ñ£­£­¹ãÎ÷Ò½¿Æ´óѧ¸½ÊôÖ×ÁöÒ½Ôº¸¾Áö¿Æ£»1997.8£­2003.8£­£­¹ðÁÖÊеÚËÄÈËÃñÒ½Ôº¸¾²ú¿Æ
µÚÒ»×÷Õß»òͨѶ×÷Õß·¢±íÂÛÎÄ:
1.?Yang?Z,?Chen?D,?Zhang?J,?Yao?D,?Gao?K,?Wang?H,?Liu?C,?Yu?J,?Li?L.?The?efficacy?and?safety?of?neoadjuvant?chemotherapy?in?the?treatment?of?locally?advanced?cervical?cancer:?A?randomized?multicenter?study.Gynecol?Oncol.?2015?Jun?23.?pii:?S0090-8258(15)30048-2.?doi:?10.1016/j.ygyno.2015.06.027.?[Epub?ahead?of?print]2.?Yang?ZJ,?Liu?ZC,?Wei?RJ,?Li?L.?An?Analysis??of?Prognostic?Factors?in?Patients?with?Ovarian?Malignant?Germ?Cell?Tumors?Who?Are?Treated?withFertility-Preserving?Surgery.?Gynecol?Obstet?Invest.?201681(1):1-9?3.?Yan-ying?Feng,?Zhi-jun?Yang*.?The?Clinical?Application?of?the?Heart?Rate?eceleration?Capacity?Test?to?Predict?Epirubicin-Induced?Cardiotoxicity.??J?Cardiovasc?Pharmacol.??2015?Oct66(4):371-5.?4.?Zhijun?Yang*,?Chunyin?Wei,*?Zhaoqing?Luo,?Li?Li.The?clinical?value?of?the?serum?HE4?assay?in?the?diagnosis?of?ovarian?cancer£ºA?meta-analysis.?Onco?Targets?Ther.?2013?Jul?236:957-66.5.?Zhijun?Yang,Zhaoqin?Luo,?Bingnig?Zhao,?Wei?Zhang,?Jieqing?Zhang,?Zhuang?LI,?LI?LI?*.Diagnosis?and?preoperative?predictive?value?of?serum?HE4?concentrations?for?optimal?debulking?in?epithelial?ovarian?cancer.?Oncol?Lett.?2013?Jul?6(1):?28¨C34..2013.6(1):28-34.6.Âѳ²ÉÏƤÐÔ°©Ïà¹Ø¿¹Ô­µÄɸѡºÍѪÇåѧ¼ì²â£¬Öлª¸¾²ú¿ÆÔÓÖ¾£»2007£¬42£¨12£©£¬834-839¡£(ÖÐÎĺËÐÄ)7.BARD1¼ôÇбäÒìÌåµÄ×ÔÉí¿¹ÌåÔÚÂѳ²¶ñÐÔÖ×ÁöÕï¶ÏÖеÄÁÙ´²¼ÛÖµ£¬Öлª¸¾²ú¿ÆÔÓÖ¾£¬2008£¬43£¨9£©£¬680-684¡£(ÖÐÎĺËÐÄ)8.ѪÇåÖÐÖ×ÁöÏà¹Ø¿¹Ô­×ÔÉí¿¹ÌåÆ×ÓëCA125ÁªºÏ¼ì²âÔÚÂѳ²¶ñÐÔÖ×ÁöÕï¶Ï¼°²¡Çé¼à²âÖеļÛÖµ£¬Öлª¸¾²ú¿ÆÔÓÖ¾£¬2011£¬46£¨2£©£º113-118¡£(ÖÐÎĺËÐÄ)9.¸¹Ç»¾µÏ¹㷺ÐÔ×Ó¹¬ÇгýÖÎÁÆÔçÆÚ×Ó¹¬¾±°©µÄÁÆЧ¼°¶Ô»¼ÕßÔ¤ºóºÍÉúÃüÖÊÁ¿µÄÓ°Ï죬Öлª¸¾²ú¿ÆÔÓÖ¾£¬2011£¬46£¨11£©£º854-859¡£(ÖÐÎĺËÐÄ)10.Âѳ²¶ñÐÔÉúֳϸ°ûÖ×Áö±£ÁôÉúÓý¹¦ÄÜÊÖÊõ»¼ÕßÔ¤ºó¼°ÉúÓý¹¦ÄܵÄÓ°ÏìÒòËØ·ÖÎö£¬Öлª¸¾²ú¿ÆÔÓÖ¾£¬2012£¬47£¨12£©£º898-904¡£(ÖÐÎĺËÐÄ)11.¸¹Ç»¾µÔÚÂѳ²¶ñÐÔÖ×ÁöÊÖÊõÖеÄÓ¦Óã¬Öлª¸¾²ú¿ÆÔÓÖ¾£¬2010£¬45£¨9£©718-719¡£(ÖÐÎĺËÐÄ)12.×Ó¹¬¾±Ð¡Ï¸°ûÉñ¾­ÄÚ·ÖÃÚ°©µÄÁÙ´²²¡Àí·ÖÎö£¬Öлª¸¾²ú¿ÆÔÓÖ¾£¬2011£¬46£¨5£©£º360-363£¨Í¨Ñ¶×÷Õߣ©¡£(ÖÐÎĺËÐÄ)13.ÑôÖ¾¾ü.´ÙÅÅÂÑÖÎÁƺó·¢ÏÖÂѳ²ÉÏƤÐÔ°©2Àý,Öлª¸¾²ú¿ÆÔÓÖ¾£¬2013£¬48£¨1£©£º77-78¡£(ÖÐÎĺËÐÄ)14.¸¾¿ÆÖ×ÁöÊÖÊõѪ¹ÜËðÉ˼°³öѪµÄÔ¤·À¼°´¦Àí£¬ÖйúʵÓø¾¿ÆÓë²ú¿ÆÔÓÖ¾£¬2009£¬25£¨7£©£º485-487¡£(ÖÐÎĺËÐÄ)15.?µ³²ÊÁᣬÀîÁ¦£¬ñû½ð´º£¬ÕŽàÇ壬ÑôÖ¾¾ü.Ó°Ï츴·¢ÉÏƤÐÔÂѳ²°©»¯ÁÆÁÆЧµÄÁÙ´²²¡ÀíÒòËØ·ÖÎö£¬ÏÖ´ú¸¾²ú¿Æ½øÕ¹,2013,22(4):279-283¡£(ÖÐÎĺËÐÄ)?£¨Í¨Ñ¶×÷Õߣ©16.PBL½ÌѧģʽÔÚ¸¾¿ÆÖ×ÁööλÔÓéÀֵǼÈë¿ÚÏÂÔØѧλÑо¿ÉúÅàÑøÖеÄÓ¦Ó㬽Ìʦ½ÌÓýÑо¿£¬2011£¬23£¨2£©£º53-54¡£(ÖÐÎĺËÐÄ)17.FXR1»ùÒò¹ý±í´ï¶ÔÂѳ²°©Ï¸°ûÉúÎïѧÐÐΪӰÏìµÄ³õ²½Ñо¿£¬Öйú°©Ö¢ÔÓÖ¾,2012,22(6):413-418¡£(ÖÐÎĺËÐÄ)18.¸¹Ç»¾µÏÂIIIÐ͸ùÖÎÐÔ×Ó¹¬Çгý¼°¸¹Ä¤ºóÁܰͽáÇгý20Àý·ÖÎö£¬ÊµÓø¾²ú¿ÆÔÓÖ¾£¬2011£¬27£¨6£©£º452-454¡£(ÖÐÎĺËÐÄ)19.×Ó¹¬ÈâÁöµÄзÖÆÚÓëÁÙ´²ÒâÒ壬ʵÓø¾²ú¿ÆÔÓÖ¾£¬2011£¬27£¨6£©£º410-412¡£(ÖÐÎĺËÐÄ)20.Âѳ²ÉÏƤÐÔ°©Ïà¹Ø¿¹Ô­É¸Ñ¡ÖÐSEREX¼¼ÊõµÄÓ¦Ó㬹ú¼Ê¸¾²ú¿ÆѧÔÓÖ¾(Ô­¹úÍâҽѧ¸¾²ú¿Æѧ·Ö²á)£»2008£¬35£¨4£©£¬238-241¡£21.dz̸Ӧ½ìҽѧ˶ʿÑо¿ÉúµÄÅàÑø£¬¹ãÎ÷Ò½¿Æ´óѧѧ±¨£»2009£¬26£¬50-51¡£22.Âѳ²ÉÏƤÐÔ°©SEREX¿¹Ô­»ùÒòFXR1¡¢OV-189Ô­ºË±í´ïÔØÌåµÄ¹¹½¨¼°±í´ï£¬¹ãÎ÷Ò½¿Æ´óѧѧ±¨£»2008£¬25£¨2£©£¬184-187¡£23.Âѳ²ÉÏƤÐÔ°©Ïà¹Ø¿¹Ô­cDNA±í´ïÎÄ¿âµÄ¹¹½¨£¬¹ãÎ÷Ò½¿Æ´óѧѧ±¨£»2008£¬25£¨4£©£¬505-507¡£24.Âѳ²°©Ïà¹Ø¿¹Ô­cDNA±í´ïÎÄ¿âµÄɸÑ¡£¬¹ãÎ÷Ò½¿Æ´óѧѧ±¨£»2008£¬25£¨6£©£¬920-923¡£25.ÈçºÎ×öºÃÒ»¸öÁÙ´²Óë¿ÆÑÐÈ«Ãæ·¢Õ¹µÄҽѧ²©Ê¿Ñо¿Éú£¬¸ß½ÌÂÛ̳£»×ܵÚ109ÆÚ(2008ÄêµÚ5ÆÚ)£¬213-214¡£26.Âѳ²ÉÏƤÐÔ°©SEREX¿¹Ô­»ùÒòTM4SF1¡¢C1D¡¢TIZÔ­ºË±í´ïÔØÌåµÄ¹¹½¨Óë±í´ï£¬¹ãÎ÷Ò½¿Æ´óѧѧ±¨£¬2009£¬26£¨3£©£¬362-365¡£27.¸¹Ç»¾µÔÚÂѳ²¶ñÐÔÖ×ÁöÔÙ·ÖÆÚÊÖÊõÖеÄÓ¦Óã¬Ö×ÁöÔ¤·ÀÓëÖÎÁÆ£¬2011£¬24£¨1£©£º23-25¡£28.Âѳ²ÉÏƤÐÔ°©Ïà¹Ø¿¹Ô­»ùÒòFXR1µÄ±í´ï¼°ÆäÁÙ´²¼ÛÖµ£¬¹ãÎ÷Ò½¿Æ´óѧѧ±¨£¬2011£¬28£¨2£©£º276-277¡£29.FXR1×ÔÉí¿¹ÌåÔÚÂѳ²°©µÄÕï¶Ï¼ÛÖµ£¬¹ãÎ÷Ò½¿Æ´óѧѧ±¨£¬2011£¬28£¨3£©£º408-410¡£30.Âѳ²°©ÊÖÊõÖ㦵À²¡Ôî´¦Àí¶ÔÔ¤ºóÓ°ÏìµÄÑ­Ö¤ÆÀ¼Û£¬¹ãÎ÷Ò½¿Æ´óѧѧ±¨£¬2012£¬29£¨4£©£º547-552¡££¨Í¨Ñ¶×÷Õߣ©